DKSH has signed an agreement to acquire Taqkey and Quantum, expanding its presence in the Asia-Pacific life sciences market through their extensive distribution network and established client relationships.
Target Company Information
DKSH has announced its intention to acquire Taqkey and Quantum, two prominent distributors of life science reagents and consumables based in Taiwan. Founded in 2002, Taqkey operates out of Miaoli and employs over 60 individuals. Together with Quantum, the companies generate annual net sales exceeding CHF 13 million while maintaining strong profitability. They have established long-term relationships with esteemed blue-chip clients within the life science sector, bolstering their reputation in the market. The joint operations of Taqkey and Quantum are complemented by a network of seven sales offices and three warehouses across Taiwan.
Industry Overview in Taiwan
The life sciences industry in Taiwan has seen substantial growth over the last decade, driven by an increased focus on research and development. Fostering innovation, Taiwan has positioned itself as a hub for biotechnology and pharmaceutical companies, creating a competitive landscape in the region. The government's support for life science initiatives, coupled with a skilled workforce, reinforces Taiwan's status as an attractive market for foreign investments.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Furthermore, Taiwan's strategic geographic location in Asia enables easy access to major markets such as China and Southeast Asia, promoting trade and collaboration. This accessibility enhances supply chain efficienc
Similar Deals
Mehiläinen → Regina Maria and MediGroup
2024
DKSH
invested in
Taqkey and Quantum
in 2025
in a Buyout deal
Disclosed details
Revenue: $0M